IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells

Journal of Experimental Medicine

Volumn 210, Issue 3, 2013, Pages 491-502

  Ben Sasson, Shlomo Z ^a,d   Hogg, Alison ^b   Hu Li, Jane ^a   Wingfield, Paul ^c   Chen, Xi ^a   Crank, Michelle ^a   Caucheteux, Stephane ^a   Ratner Hurevich, Maya ^d   Berzofsky, Jay A ^b   Nir Paz, Ran ^d   Paul, William E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL MIGRATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE RELEASE; CYTOTOXICITY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; INTERFERON PRODUCTION; LIVER CELL; LUNG ALVEOLUS CELL; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TISSUE DISTRIBUTION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LISTERIA MONOCYTOGENES;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNIZATION; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-1; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

MLCS; MLOWN;

EID: 84877627620     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20122006     Document Type: Article

References (48)

1. Ben-Sasson, S.Z., J. Hu-Li, J. Quiel, S. Cauchetaux, M. Ratner, I. Shapira, C.A. Dinarello, and W.E. Paul. 2009. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc. Natl. Acad. Sci. USA. 106:7119-7124. http://dx.doi.org/10.1073/pnas.0902745106
2. Bonilla, W.V., A. Fröhlich, K. Senn, S. Kallert, M. Fernandez, S. Johnson, M. Kreutzfeldt, A.N. Hegazy, C. Schrick, P.G. Fallon, et al. 2012. The alarmin interleukin-33 drives protective antiviral CD8+ T cell responses. Science. 335:984-989. http://dx.doi.org/10.1126/science.1215418
3. Chi, H. 2012. Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12:325-338.
4. Curtsinger, J.M., C.S. Schmidt, A. Mondino, D.C. Lins, R.M. Kedl, M.K. Jenkins, and M.F. Mescher. 1999. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J. Immunol. 162:3256-3262.
5. Ding, Z., K. Xiong, and T.B. Issekutz. 2000. Regulation of chemokine-induced transendothelial migration of T lymphocytes by endothelial activation: differential effects on naive and memory T cells. J. Leukoc. Biol. 67:825-833.
6. Earl, P.L., S. Koenig, and B. Moss. 1991. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65:31-41.
7. Elkabets, M., Y. Krelin, S. Dotan, A. Cerwenka, A. Porgador, R.G. Lichtenstein, M.R. White, M. Zoller, Y. Iwakura, C.A. Dinarello, et al. 2009. Host-derived interleukin-1alpha is important in determining the immunogenicity of 3-methylcholantrene tumor cells. J. Immunol. 182:4874-4881. http://dx.doi.org/10.4049/jimmunol.0803916
8. Feltkamp, M.C., H.L. Smits, M.P. Vierboom, R.P. Minnaar, B.M. de Jongh, J.W. Drijfhout, J. ter Schegget, C.J. Melief, and W.M. Kast. 1993. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16- transformed cells. Eur. J. Immunol. 23:2242-2249. http://dx.doi.org/10.1002/eji.1830230929
9. Fischer, H., G. Hedlund, T. Kalland, H.O. Sjögren, and M. Dohlsten. 1990. Independent regulation of IFN-gamma and tumor necrosis factor by IL-1 in human T helper cells. J. Immunol. 145:3767-3772.
10. Freedman, D.O., S. Parker-Cook, M.C. Maia e Silva, C. Braga, and A. Maciel. 1996. Very late antigen-4/vascular cell adhesion molecule-1 (VLA-4/VCAM-1) pathway is involved in the transendothelial migration of lymphocytes in bancroftian filariasis. J. Immunol. 156:2901-2908.
11. Fremond, C.M., D. Togbe, E. Doz, S. Rose, V. Vasseur, I. Maillet, M. Jacobs, B. Ryffel, and V.F. Quesniaux. 2007. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 179:1178-1189.
12. Ghiringhelli, F., L. Apetoh, A. Tesniere, L. Aymeric, Y. Ma, C. Ortiz, K. Vermaelen, T. Panaretakis, G. Mignot, E. Ullrich, et al. 2009. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1betadependent adaptive immunity against tumors. Nat. Med. 15:1170-1178. http://dx.doi.org/10.1038/nm.2028
13. Gowda, N.M., X. Wu, and D.C. Gowda. 2012. TLR9 and MyD88 are crucial for the development of protective immunity to malaria. J. Immunol. 188:5073-5085. http://dx.doi.org/10.4049/jimmunol.1102143
14. Gulen, M.F., Z. Kang, K. Bulek, W. Youzhong, T.W. Kim, Y. Chen, C.Z. Altuntas, K. Sass Bak-Jensen, M.J. McGeachy, J.S. Do, et al. 2010. The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity. 32:54-66. http://dx.doi.org/10.1016/j.immuni.2009.12.003
15. Guo, L., G. Wei, J. Zhu, W. Liao, W.J. Leonard, K. Zhao, and W. Paul. 2009. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc. Natl. Acad. Sci. USA. 106:13463-13468. http://dx.doi.org/10.1073/pnas.0906988106
16. Halvorsen, R., G. Gaudernack, T. Leivestad, F. Vartdal, and E. Thorsby. 1987. Activation of resting, pure CD4+, and CD8+ cells via CD3. Requirements for second signals. Scand. J. Immunol. 26:197-205. http://dx.doi.org/10.1111/j.1365-3083.1987.tb02252.x
17. Hope, J.C., P. Sopp, R.A. Collins, and C.J. Howard. 2001. Differences in the induction of CD8+ T cell responses by subpopulations of dendritic cells from afferent lymph are related to IL-1 alpha secretion. J. Leukoc. Biol. 69:271-279.
18. Ichinohe, T., H.K. Lee, Y. Ogura, R. Flavell, and A. Iwasaki. 2009. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206:79-87. http://dx.doi.org/10.1084/jem.20081667
19. Joeckel, L.T., R. Wallich, S.S. Metkar, C.J. Froelich, M.M. Simon, and C. Borner. 2012. Interleukin-1R signaling is essential for induction of proapoptotic CD8 T cells, viral clearance, and pathology during lymphocytic choriomeningitis virus infection in mice. J. Virol. 86:8713-8719. http://dx.doi.org/10.1128/JVI.00682-12
20. Kanda, T., M. Yamawaki, T. Ariga, and R.K. Yu. 1995. Interleukin 1 beta upregulates the expression of sulfoglucuronosyl paragloboside, a ligand for L-selectin, in brain microvascular endothelial cells. Proc. Natl. Acad. Sci. USA. 92:7897-7901. http://dx.doi.org/10.1073/pnas.92.17.7897
21. Klarnet, J.P., D.E. Kern, S.K. Dower, L.A. Matis, M.A. Cheever, and P.D. Greenberg. 1989. Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2. J. Immunol. 142:2187-2191.
22. Kohlmeier, J.E., T. Cookenham, A.D. Roberts, S.C. Miller, and D.L. Woodland. 2010. Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge. Immunity. 33:96-105. http://dx.doi.org/10.1016/j.immuni.2010.06.016
23. Lee, W.W., S.W. Kang, J. Choi, S.H. Lee, K. Shah, E.E. Eynon, R.A. Flavell, and I. Kang. 2010. Regulating human Th17 cells via differential expression of IL-1 receptor. Blood. 115:530-540. http://dx.doi.org/10.1182/blood-2009-08-236521
24. Lye, E., S. Dhanji, T. Calzascia, A.R. Elford, and P.S. Ohashi. 2008. IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses. Eur. J. Immunol. 38:870-876. http://dx.doi.org/10.1002/eji.200737429
25. McAleer, J.P., D.J. Zammit, L. Lefrançois, R.J. Rossi, and A.T. Vella. 2007. The lipopolysaccharide adjuvant effect on T cells relies on nonoverlapping contributions from the MyD88 pathway and CD11c+ cells. J. Immunol. 179:6524-6535.
26. McCandless, E.E., M. Budde, J.R. Lees, D. Dorsey, E. Lyng, and R.S. Klein. 2009. IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis. J. Immunol. 183:613- 620. http://dx.doi.org/10.4049/jimmunol.0802258
27. McConkey, D.J., P. Hartzell, S.C. Chow, S. Orrenius, and M. Jondal. 1990. Interleukin 1 inhibits T cell receptor-mediated apoptosis in immature thymocytes. J. Biol. Chem. 265:3009-3011.
28. Mizuochi, T., D.J. McKean, and A. Singer. 1988. IL-1 as a co-factor for lymphokine-secreting CD8+ murine T cells. J. Immunol. 141: 1571-1575.
29. Mohamadzadeh, M., H. DeGrendele, H. Arizpe, P. Estess, and M. Siegelman. 1998. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J. Clin. Invest. 101:97-108. http://dx.doi.org/10.1172/JCI1604
30. Muehlhoefer, A., L.J. Saubermann, X. Gu, K. Luedtke-Heckenkamp, R. Xavier, R.S. Blumberg, D.K. Podolsky, R.P. MacDermott, and H.C. Reinecker. 2000. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J. Immunol. 164:3368-3376.
31. Nagoya, S., P.D. Greenberg, C. Yee, K.E. Weisser, H. Sugawara, M.B. Widmer, J. Slack, S.K. Dower, S.D. Lupton, and R.W. Overell. 1994. Helper T cellindependent proliferation of CD8+ cytotoxic T lymphocytes transduced with an IL-1 receptor retrovirus. J. Immunol. 153:1527-1535.
32. Palmer, G., and C. Gabay. 2011. Interleukin-33 biology with potential insights into human diseases. Nat Rev Rheumatol. 7:321-329. http://dx.doi.org/10.1038/nrrheum.2011.53
33. Panzer, S., R.L. Geller, and F.H. Bach. 1990. Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a costimulatory factor for CD4+CD29+CD45RA- T cells. Scand. J. Immunol. 32:359-371. http://dx.doi.org/10.1111/j.1365-3083.1990.tb02930.x
34. Pietschmann, P., J.J. Cush, P.E. Lipsky, and N. Oppenheimer-Marks. 1992. Identification of subsets of human T cells capable of enhanced transendothelial migration. J. Immunol. 149:1170-1178.
35. Sheng, K.C., M. Kalkanidis, D.S. Pouniotis, M.D. Wright, G.A. Pietersz, and V. Apostolopoulos. 2008. The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells. J. Immunol. 181:2455-2464.
36. Sikorski, E.E., R. Hallmann, E.L. Berg, and E.C. Butcher. 1993. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1. J. Immunol. 151:5239-5250.
37. Staib, C., S. Kisling, V. Erfle, and G. Sutter. 2005. Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara. J. Gen. Virol. 86:1997-2006. http://dx.doi.org/10.1099/vir.0.80646-0
38. Stocker, C.J., K.L. Sugars, O.A. Harari, R.C. Landis, B.J. Morley, and D.O. Haskard. 2000. TNF-alpha, IL-4, and IFN-gamma regulate differential expression of P- and E-selectin expression by porcine aortic endothelial cells. J. Immunol. 164:3309-3315.
39. Takahashi, H., J. Cohen, A. Hosmalin, K.B. Cease, R. Houghten, J.L. Cornette, C. DeLisi, B. Moss, R.N. Germain, and J.A. Berzofsky. 1988. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 85:3105-3109. http://dx.doi.org/10.1073/pnas.85.9.3105
40. Takeshita, T., H. Takahashi, S. Kozlowski, J.D. Ahlers, C.D. Pendleton, R.L. Moore, Y. Nakagawa, K. Yokomuro, B.S. Fox, D.H. Margulies, and J.A. Berzofsky. 1995. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. J. Immunol. 154:1973-1986.
41. Thompson, A.L., B.T. Johnson, G.D. Sempowski, M.D. Gunn, B. Hou, A.L. DeFranco, and H.F. Staats. 2012. Maximal adjuvant activity of nasally delivered IL-1? requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production. J. Immunol. 188:2834-2846. http://dx.doi.org/10.4049/jimmunol.1100254
42. von Rossum, A., R. Krall, N.K. Escalante, and J.C. Choy. 2011. Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression. J. Biol. Chem. 286:21137-21144. http://dx.doi.org/10.1074/jbc.M110.197657
43. Wang, Y.F., V.L. Calder, J. Greenwood, and S.L. Lightman. 1993. Lymphocyte adhesion to cultured endothelial cells of the blood-retinal barrier. J. Neuroimmunol. 48:161-168. http://dx.doi.org/10.1016/0165-5728(93)90188-5
44. Weber, A., P. Wasiliew, and M. Kracht. 2010. Interleukin-1 (IL-1) pathway. Sci. Signal. 3:cm1. http://dx.doi.org/10.1126/scisignal.3105cm1
45. Wesa, A., and A. Galy. 2002. Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand. BMC Immunol. 3:14. http://dx.doi.org/10.1186/1471-2172-3-14
46. Wingfield, P., M. Payton, J. Tavernier, M. Barnes, A. Shaw, K. Rose, M.G. Simona, S. Demczuk, K. Williamson, and J.M. Dayer. 1986. Purification and characterization of human interleukin-1 beta expressed in recombinant Escherichia coli. Eur. J. Biochem. 160:491-497. http://dx.doi.org/10.1111/j.1432-1033.1986.tb10066.x
47. Zhao, Y., C. De Trez, R. Flynn, C.F. Ware, M. Croft, and S. Salek-Ardakani. 2009. The adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus. J. Immunol. 182:6278-6286. http://dx.doi.org/10.4049/jimmunol.0803682
48. Zhu, Q., C. Egelston, S. Gagnon, Y. Sui, I.M. Belyakov, D.M. Klinman, and J.A. Berzofsky. 2010. Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J. Clin. Invest. 120:607-616. http://dx.doi.org/10.1172/JCI39293